Djentinga

Low Risk Long Entry SELB

Long
Djentinga Updated   
NASDAQ:SELB   None
1. Price near support + trendline.
2. Bullish divergence on the MACD.
3. ADX below 20 indicating that the sell off is weak.
4. Low volume sell off in line with rest of market/XBI.
5. Insider Dr. Timothy Springer (who made ~17000% on MRNA) keeps buying millions of shares above this level.

Trade closed: stop reached:
Not yet it seems :)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.